Serum matrix metalloproteinases in patients resuscitated from cardiac arrest. The association with therapeutic hypothermia

Resuscitation

Volumn 83, Issue 2, 2012, Pages 197-201

  Hästbacka, Johanna ^a   Tiainen, Marjaana ^a   Hynninen, Marja ^a   Kolho, Elina ^a   Tervahartiala, Taina ^a   Sorsa, Timo ^a   Lauhio, Anneli ^a,b   Pettilä, Ville ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cardiac arrest; Hypothermia; Ischaemia; Matrix metalloproteinase; Post resuscitation period

Indexed keywords

C REACTIVE PROTEIN; GELATINASE B; MATRILYSIN; NEURON SPECIFIC ENOLASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART ARREST; HUMAN; HUMAN TISSUE; INDUCED HYPOTHERMIA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESUSCITATION; RETURN OF SPONTANEOUS CIRCULATION;

AGED; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; CARDIOPULMONARY RESUSCITATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ARREST; HUMANS; HYPOTHERMIA, INDUCED; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84856492152     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2011.07.036     Document Type: Article

References (40)

1. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346:549-556. The Hypothermia After Cardiac Arrest (HACA) study investigators.
2. Bernard S.A., Gray T.W., Buist M.D., et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346:557-563.
3. Ginsberg M.D., Sternau L.L., Globus M.Y.-T., Dietrich W.D., Busto R. Therapeutic modulation of brain temperature: relevance of ischemic brain injury. Cerebrovasc Brain Metab Rev 1992, 4:189-225.
4. Lee J.E., Yoon Y.J., Moseley M.E., Yenari M.A. Reduction in the levels of matrix metalloproteinases and increased expression of tissue inhibitor of metalloproteinase-2 in response to mild hypothermia therapy in experimental stroke. J Neurosurg 2005, 103:289-297.
5. Wagner S., Nagel S., Kluge B., et al. Topographically graded postischemic presence of metalloproteinases is inhibited by hypothermia. Brain Res 2003, 984:63-75.
6. Horstmann S., Kalb P., Koziol J., Gardner H., Wagner S. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients. Influence of different therapies. Stroke 2003, 34:2165-2172.
7. Suehiro E., Fujisawa H., Akimura T., et al. Increased matrix metalloproteinase-9 in blood in association with activation of interleukin-6 after traumatic brain injury: influence of hypothermic therapy. J Neurotrauma 2004, 21:1706-1711.
8. Truettner J.S., Alonso O.F., Dietrich W.D. Influence of therapeutic hypothermia on matrix metalloproteinase activity after traumatic brain injury in rats. J Cereb Blood Flow Metab 2005, 25:1505-1516.
9. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Ann Rev Cell Dev Biol 2001, 17:463-516.
10. Rosenberg G.A., Estrada E.Y., Dencoff J.E., Stetler-Stevenson W.G. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res 1995, 703:151-155.
11. Rosenberg G.A., Kornfeld M., Estrada E., Kelley R.O., Liotta L.A., Stetler-Stevenson W.G. TIMP-2 reduces proteolytic opening of the blood-brain barrier by type IV collagenase. Brain Res 1992, 576:203-207.
12. Magnoni S., Baker A., George S.J., et al. Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice. Neurobiol Dis 2004, 17:188-197.
13. Lee S.-R., Tsuji K., Lee S.-R., Lo E.H. Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci 2004, 24:671-678.
14. Lorente L., Martín M., Labarta L., et al. Matrix metalloproteinase -9, -10 and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care 2009, 13:R158.
15. Adrie C., Laurent I., Monchi M., Cariou A., Dhainaou J.-F., Spaulding C. Postresuscitation disease after cardiac arrest: a sepsis-like syndrome?. Curr Opin Crit Care 2004, 10:208-212.
16. Hästbacka J., Hynninen M., Kolho E., et al. Collagenase 2/matrix metalloproteinase 8 in critically ill patients with secondary peritonitis. Shock 2007, 27:145-150.
17. Pradhan-Palikhe P., Vikatmaa P., Lajunen T., et al. Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm. Scand J Immunol 2010, 72:150-157.
18. Rautelin H.I., Oksanen A.M., Veijola L.I., et al. Enhanced systemic matrix metalloproteinase response in helicobacter pylori gastritis. Ann Med 2009, 41:208-215.
19. Tiainen M., Roine R.O., Pettilä V., Takkunen O. Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia. Stroke 2003, 34:2881-2886.
20. Guyatt G.H., Sackett D.L., Cook D.J. User's guide to the medical literature II. How to use an article about therapy or prevention B. What were the results and will they help me in caring for my patients?. JAMA 1994, 271:59-63. Evidence-based medicine working group.
21. Planas A.M., Solé S., Justicia C. Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol Dis 2001, 8:834-846.
22. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats. Inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998, 29:1020-1030.
23. Clark A.W., Krekoski C.A., Bou S.-S., Chapman K.R., Edwards D.R. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett 1997, 238:53-56.
24. Montaner J., Alvarez-Sabín J., Molina C.A., et al. Matrix metalloproteinase expression after human cardioembolic stroke. Stroke 2001, 32:1759-1766.
25. Castellanos M., Leira R., Serena J., et al. Plasma Metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 2003, 34:40-46.
26. Rosenberg G.A., Cunningham L.A., Wallace J., et al. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 2001, 893:104-112.
27. Campbell I.L., Pagenstecher A. Matrix metalloproteinases and their inhibitors in the nervous system: the good, bad and the enigmatic. Trends Neurosci 1999, 22:285-287.
28. Elkington P., O'Kane C., Friedland J. The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 2005, 142:12-20.
29. Garcia J., Liu K., Yoshida Y., Lian J., Chen S., del Zoppo G. Influx of leucocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol 1994, 144:188-199.
30. Rosenberg G.A., Estrada E.Y., Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998, 29:2189-2195.
31. Hamann G.F., Okada Y., del Zoppo G.J. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J Cereb Blood Flow Metab 1996, 16:1373-1378.
32. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function, and biochemistry. Circ Res 2003, 92:827-839.
33. Owen C.A., Campbell E.J. The cell biology of leukocyte-mediated proteolysis. J Leukoc Biol 1999, 65:137-150.
34. Fasciglione G.F., Marini S., D'Alessio S., Politi V., Coletta M. pH and temperature dependence of functional modulation in metalloproteinases. A comparison between neutrophil collagenase and gelatinases A and B. Biophys J 2000, 79:2138-2149.
35. Vinardi S., Pierro A., Parkinson E., et al. Hypothermia throughout intestinal ischemia-reperfusion injury attenuates lung neutrophil infiltration. J Ped Surg 2009, 38:88-91.
36. Callaway C., Rittenberger J., Logue E., McMichael M. Hypothermia after cardiac arrest does not alter serum inflammatory markers. Crit Care Med 2008, 36:2607-2612.
37. Fries M., Stoppe C., Brücken D., Rossaint R., Kuhlen R. Influence of mild therapeutic hypothermia on the inflammatory response after successful resuscitation from cardiac arrest. J Crit Care 2009, 24:453-457.
38. Kouenhowen M., Carlström C., Ozenci V., Link H. Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke. J Clin Immunol 2001, 21:365-375.
39. Wilson C.L., Matrisian L.M. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996, 28:123-136.
40. Fujimura M., Gasche Y., Morita-Fujimura Y., Massengale J., Kawase M., Chan P.H. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 1999, 842:92-100.